Ibacitabine
|
Names
|
IUPAC name
2′-Deoxy-5-iodocytidine
|
Systematic IUPAC name
4-Amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2(1H)-one
|
Identifiers
|
|
|
|
|
ChEMBL
|
|
ChemSpider
|
|
ECHA InfoCard
|
100.009.337
|
KEGG
|
|
|
|
UNII
|
|
|
|
InChI=1S/C9H12IN3O4/c10-4-2-13(9(16)12-8(4)11)7-1-5(15)6(3-14)17-7/h2,5-7,14-15H,1,3H2,(H2,11,12,16)/t5-,6+,7+/m0/s1 NKey: WEVJJMPVVFNAHZ-RRKCRQDMSA-N NInChI=1/C9H12IN3O4/c10-4-2-13(9(16)12-8(4)11)7-1-5(15)6(3-14)17-7/h2,5-7,14-15H,1,3H2,(H2,11,12,16)/t5-,6+,7+/m0/s1 Key: WEVJJMPVVFNAHZ-RRKCRQDMBC
|
OCC1[C@@H](O)C[C@@H](O1)N2C=C(I)C(N)=NC2=O
|
Properties
|
|
C9H12IN3O4
|
Molar mass
|
353.11375
|
Pharmacology
|
|
D06BB08 (WHO)
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Chemical compound
Ibacitabine (or ibacitabin,[1] or 5-iodo-2'-deoxycytidine ) is an antiviral drug. It is topically applied to treat herpes labialis.[2]
- ^ Serpentier-Daude, A.; Collet, E.; Didier, A. F.; Touraud, J. P.; Sgro, C.; Lambert, D. (February 2000). "[Contact dermatitis to topical antiviral drugs]". Ann Dermatol Venereol. 127 (2): 191–3. PMID 10739980.
- ^ Groot, Anton C. de (2021). Topical drugs (First ed.). Boca Raton, FL: CRC Press. p. 421. ISBN 9781000367867.